GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease

Qing-Ao Xiao(China Three Gorges University), Xuan Xia(Sun Yat-sen University), Jun Zeng(China Three Gorges University), Qian He(Academy of Medical Sciences)
Biomedicine & Pharmacotherapy
December 24, 2021
10.1016/j.biopha.2021.112582
Cited by 50

Related Papers

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
|PLoS ONE|2011|260
Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials
|Medical Science Monitor|2017|173
Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies
|Journal of Clinical Neurology|2019|93
Maintenance Therapy With Continuous or Switch Strategy in Advanced Non-small Cell Lung Cancer
|CHEST Journal|2011|71
A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
|Scientific Reports|2018|56